tumor expansion trial
Scope
Date
~
-
Electric vehicles
POSCO Int’l to invest $519 mn in EV parts output expansion
POSCO International Corp., the energy and trading unit of South Korea’s steel giant POSCO Holdings Inc., plans to spend 680 billion won ($519....
Nov 09, 2023 (Gmt+09:00)
-
Electric vehicles
SK On signs deal to supply NCM battery cells to Sweden’s Polestar 5 EV
SK On Co., the battery-making affiliate of South Korea’s SK Group, has signed a deal to supply nickel-cobalt-manganese (NCM) battery cell modu...
Nov 06, 2023 (Gmt+09:00)
-
Banking & Finance
DGB partners with Vietnamese IT company
South Korea's DGB Financial Group announced on Monday it signed a business agreement with the global IT company FPT Software at the FPT Group headqu...
Nov 06, 2023 (Gmt+09:00)
-
Earnings
Naver posts record Q3 sales, profit on e-commerce
South Korea’s web portal giant Naver Corp. on Friday posted record sales and operating profit in the third quarter, driven by robust sales gro...
Nov 03, 2023 (Gmt+09:00)
-
Retail
E-Land eyes another leap forward in China under new strategy
SHANGHAI – E-Land World Ltd., a South Korean fashion and retail company, is gearing up for another leap forward in China, where the company&rs...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Leadership & Management
Mirae Asset promotes Indian unit head to vice chairman
Mirae Asset Financial Group, South Korea’s leading financial conglomerate, on Monday promoted Swarup Mohanty, the head of its Indian asset man...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Korean startups
Ably's amood to support K-fashion's expansion into Japan
South Korean fashion commerce platform Ably Corp. announced on Wednesday its Japanese shopping platform amood starts a one-stop service for domestic...
Oct 18, 2023 (Gmt+09:00)
-
Automobiles
KCC opens US refinish color center
South Korean chemical and auto parts maker KCC Corp. opened its first overseas refinish color center in the US. According to the company's anno...
Oct 13, 2023 (Gmt+09:00)
-
Korean food
Lotte Wellfood ups Choco Pie India sales target to $60 mn with new factory
Lotte Wellfood Co., formerly Lotte Confectionery Co., has revised up this year’s Choco Pie sales forecast in India to 80 billion won ($60 mill...
Oct 10, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax's US subsidiary listed on Nasdaq
South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to conduct Phase 3 trials in Thailand for gout treatment
South Korea's JW Pharmaceutical Corp. on Thursday said it received approval from Thailand's Food and Drug Administration to conduct Phase 3 clinical...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Genome & Co.’s bile duct cancer drug candidate enters Phase 2 trials
Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...
Sep 20, 2023 (Gmt+09:00)
-
Fintech
Kakao Pay’s tie-up with Alipay spurs growth in China
BEIJING – Kakao Pay Corp., the mobile payment service unit of South Korean tech giant Kakao Corp., is rapidly growing in China’s fintech...
Sep 20, 2023 (Gmt+09:00)
-
Construction
Hyundai E&C seeks expansion to Poland, Ukraine
South Korea's Hyundai Engineering & Construction (E&C) will open a branch in Warsaw, Poland, to join a project to build small modular reacto...
Sep 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong to develop eye drops for diabetic retinopathy
South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...
Sep 15, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HMM embarks on biofuel ship pilot testing on global route
South Korea has begun a pilot operation of a biofuel-powered container ship on a global route, the government said on Friday. HMM Co.'s container sh...
Sep 15, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
Bio & Pharma
AriBio applies for Phase 3 clinical trials in China for oral dementia drug
South Korean clinical-stage biotech company AriBio Co. on Thursday said it applied for Phase 3 clinical trials on the anti-Alzheimer's candidate t...
Sep 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Yungjin Pharm's new drug candidate gets Fast Track from FDA
South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to start global clinical trials for immune-oncology drug
South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...
Aug 22, 2023 (Gmt+09:00)
-
Korean Investors
Korea taps Greyhound Capital, Headline Asia as venture fund managers
South Korean Ministry of SMEs and Startups announced the results of selecting global fund management companies for the year 2023 on Monday. The chos...
Aug 21, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma gets OK for phase 3 clinical trials of URC102 in Taiwan
South Korea's JW Pharmaceutical has won approval from Taiwan's Food and Drug Administration (TFDA) to conduct phase 3 clinical trials for its gout t...
Aug 18, 2023 (Gmt+09:00)
-
Business & Politics
Camp David Summit to Unite U.S., South Korea, Japan
WASHINGTON—A new trilateral alliance linking the U.S., South Korea and Japan will enhance cooperation among the nations in key areas, includin...
Aug 17, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Taihan Cable posts highest first-half operating profit in 20 years
South Korea's Taihan Cable & Solution Co. announced on Friday that its consolidated operating profit for the first half of this year reached 41....
Aug 11, 2023 (Gmt+09:00)
-
Economy
S.Korean think-tank lifts inflation forecast on oil prices
A South Korean government think-tank has raised its inflation prediction for this year due to the recent rise in oil prices and expectations that As...
Aug 10, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand